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Abstract Experimentation with PBX1 knockout mice has
shown that PBX1 is necessary for early embryogenesis.
Despite broad insight into PBX1 function, little is known
about the underlying target gene regulation. Utilizing the Cre–
loxP system, we targeted a functionally important part of the
homeodomain of PBX1 through homozygous deletion of
exon-6andflankingintronic regions leading toexon 7skipping
in embryonic stem (ES) cells. We induced in vitro differenti-
ation of wild-type and PBX1 mutant ES cells by aggregation
and retinoic acid (RA) treatment and compared their profiles of
gene expression at the ninth day post-reattachment to adhesive
media. Our results indicate that PBX1 interactions with HOX
proteins and DNA are dispensable for RA-induced ability of
ES to express neural genes and point to a possible involvement
of PBX1 in the regulation of imprinted genes.
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Introduction
PBX1 is a TALE (three amino acid loop extension)
family non-HOX homeodomain transcription factor in-
volved in the execution of multiple developmental
programs of gene expression. PBX1 cooperatively binds
DNA together with HOX proteins from paralogue groups
1–10 as well as several transcription factors, e.g.,
Engrailed, Pdx1, and Prep/Meis (Chang et al. 1996;L u
and Kamps 1996; Peltenburg and Murre 1996;S h e ne ta l .
1996, 1997; Knoepfler et al. 1997;B e r t h e l s e ne ta l .1998;
Goudet et al. 1999). Cooperative interactions of PBX1 and
its partner proteins modify HOX protein DNA binding
(Mann and Chan 1996). The functional importance of
these interactions has been revealed by the observation
that the PBX1 nullizygous embryos exhibit diffuse
patterning defects restrictedt ot h ed o m a i n ss p e c i f i e db y
Hox paralogues that bear the PBX dimerization motif
(Selleri et al. 2001). On the side of PBX, interactions with
HOX partners are facilitated by residues within the
homeodomain and immediate carboxy-terminal to it
(Chang et al. 1995;L ua n dK a m p s1996; Piper et al.
1999). PBX–HOX complexes are thought either to
positively or negatively regulate expression of target
genes dependent on the context of cell signaling (Saleh
et al. 2000b). In particular, activation of the protein kinase
A pathway has been shown to switch PBX–HOX
complexes from repressors to activators of transcription
(Saleh et al. 2000a). Loss of PBX1 is associated with
decreased cellular proliferation during development of
bone, pancreas, blood, kidney, and the male genital ridge
(DiMartino et al. 2001; Selleri et al. 2001;K i me ta l .
2002;S c h n a b e le ta l .2003a, b). However,itisnotclearhow
PBX1 regulates early embryonic lineage commitment. To
address this issue, we generated mouse embryonic stem cells
bearing a homozygous deletion of exon-6 of the pbx1 gene,
coding for the part of protein, which interacts with DNA and
HOX proteins. Subsequently, both the wild-type (WT) and
PBX1 mutant cells were differentiated in vitro using retinoic
acid (RA) induction/aggregation methods, and gene expres-
sion profiles of their differentiated progeny were compared.
Materials and Methods
Vector design. The PBX1
flox1 targeting vector was con-
structed by cloning of three adjacent PBX1 genomic
fragments into pflox plasmid (Chui et al. 1997; Fig. 1a).
The targeted sequence (subsequently referred to as the
target) was composed of PBX1 exon-6 (1,192–1,356 bp in
PBX1a AF020196 mRNA) flanked by 700 bp upstream
and 280 bp downstream intronic sequences (Fig. 1a).
Homologous recombination detection strategy. In the
course of PBX1
flox1 vector preparation, a HindIII restriction
digest site was removed from the genomic sequence
upstream of the targeted exon-6 (Fig. 1a). Removal of this
restriction site by enzymatic digest and Klenow polymerase
fill-in reaction allowed for Southern detection of homolo-
gous recombination events with the external Southern
probe located upstream of the vector sequences (Fig. 1a,c).
Targeting of the first allele. The NotI linearized PBX1
flox1
plasmid was electroporated into the E14 embryonic stem
(ES) cells followed by 6 d of G418 selection. The
homologous recombination positive clones were identified
using external Southern probe and two polymerase chain
reaction (PCR) systems (Fig. 2; see online Electronic
Supplementary Material for primer sequences).
CRE recombination. Cells were electroporated with 20 μg
of CMV-Cre plasmid (a kind gift of Dr. Florian Otto) and
serially diluted before plating. Colonies were picked and
PCR-analyzed for the loss of target and selection cassette
sequences (data not shown).
Targeting of the second allele. A single ES cell clone
carrying a desired deletion of target and selection cassette
sequence in the first copy of the gene (further referred to as
ΔPBX1
+/−) was subjected to the second allele targeting with
a modified PBX1
flox2 vector (Fig. 1b). In PBX1
flox2 plasmid,
target sequence was removed from between loxP sequences
by BamHI digest and re-ligation (Fig. 1b). Due to this modi-
fication, integration of PBX1
flox2 into the second copy of the
PBX1 gene causes direct exon-6 ablation without the neces-
sity of a subsequent round of CRE recombination (Fig. 1b).
ES cell culture. E14 ES cells were cultured in the presence
of1,000U/mlofrecombinantleukemiainhibitoryfactor(LIF;
ESGRO, Chemicon International, Schwalbach, Germany) on
the mitomycin (Sigma-Aldrich, Munich, Germany) treated
CD-1.MTKneo2 embryonic fibroblasts according to standard
procedures (Wasserman et al. 1993).
In vitro differentiation. The cells were differentiated
according to the previously described aggregation/RA
induction protocol (Bain et al. 1995; Gajovic et al. 1997)
with two modifications:
1. Cell culture dishes were coated with 0.1% gelatin
(Sigma)/20 μg/mllaminin(Gibco/Invitrogen,Karlsruhe,
Germany) prior to embryoid body (EB) reattachment.
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of 6 d after EB reattachment, in which time, media was
exchanged daily.
Northern blot and real-time PCR. Total RNA was isolated
from trypsinized cells using TriPure Isolation Reagent
(Boehringer Mannheim, Mannheim, Germany). Reverse
transcription was performed with TaqMan reverse transcrip-
tion reagents (Applied Biosystems, Foster City, CA) and
random hexamer primers according to supplied protocol.
The reactions were done in 30-μl volumes using SYBR
G r e e nP C Rm a s t e rm i x( A p p l i e dB i o s y s t e m s )i nt h e
ABIPrism 7900HT cycler using primers listed in Fig. 3,
Electronic Supplementary Material. Results were standard-
ized to the level of GAPDH expression using a standard
curve method according to Applied Biosystems guidelines.
Northern blots were carried out as described previously
(Uchida et al. 1994). The reverse transcriptase PCR (RT-
PCR) derived probes specific for insulin growth factor-2
(IGF-2), insulin growth factor-2 receptor (IGF-2R), insulin
growth factor-1 (IGF-1), insulin growth factor-1 receptor
(IGF-2R), H19, Oct3/4, colipase and actin were labeled
with [-
32P]dCTP (3,000 Ci/mmol; Amersham Biosciences,
Freiburg, Germany) using a Megaprime DNA labeling
system (Amersham Biosciences).
Western blot. Whole cell lysates of differentiated cells were
resolved by electrophoresis in 12% sodium dodecyl
sulfate–polyacrylamide gels and transferred onto polyviny-
Figure 1. Schematic representation of the PBX1 locus modifications.
(a) Schematic representation of the first allele targeting by homolo-
gous recombination and subsequent transient Cre recombinase
expression. The targeting vector was based on the pFlox plasmid
coding loxP flanked PGKNeo/HSV-TK selection cassette. The first
targeting vector contained a 1191-nucleotide fragment of PBX1 locus
bearing exon-6 flanked by loxP sequences. The HindIII site within the
5′ homology arm was removed from the targeting vector to allow
homologous recombination detection by Southern blot. The 5′ external
probe used for the Southern blot analysis is shown as a solid black box
above the mutated allele. H HindIII, N NotI, Bg BglII, B BamHI, E
EcoRI, S SalI. As a result of the first homologous recombination and
subsequent transient Cre expression, the sequence containing exon-6
as well as the selection cassette was removed from the first allele,
yielding neomycin-sensitive ΔPBX1
+/− ES cell clones. (b) For the
second targeting, the vector was modified by removing the target
sequence containing exon-6 with BamHI. The second round of
homologous recombination yielded neomycin-resistant ΔPBX1
−/−
clones.
Figure 2. Detection of targeted genetic modification of the PBX1
locus. (a) Southern blot analysis of PBX1 clones after the first
homologous recombination, before Cre treatment. DNAs of individual
clones resistant to G418 were digested with HindIII and analyzed by
Southern hybridization using a PCR-derived 5′ external southern
probe (for primer sequences, see Electronic Supplementary Material).
Shifts of WT 8-kb bands to 16-kb properly targeted allele bands were
detected. (b) Confirmation of Southern blot analysis by long-range −8-
kb PCR and standard −2-kb PCR on the 5′ and 3′ homology arms of
the vector. In both PCRs, one primer was based on the sequences
external to the targeting vector and one inside the vector sequence. (c)
Southern blot analysis of the clones after Cre recombination using a 5′
external hybridization probe. Cre recombinase catalyzed removal of
the selection cassette together with the target sequence resulted in a
decrease of the original 16-kb band of the correctly targeted first allele
to 11 kb ΔPBX1
+/− band (Fig. 1c). The second homologous
recombination resulted in a shift of the 8-kb WT allele band to the
14.5-kb correctly targeted second allele band.
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et al. 2003). PBX proteins were detected with PBX1/2/3 sc-
888 antibody (Santa Cruz, Heidelberg, Germany) and actin
with sc-1615 antibody (Santa Cruz).
Immunostaining. Immunostaining of β-III-tubulin and
ERK1 was performed as described previously using anti-
bodies against beta-tubulin (βIII) MMS-435P (BabCo,
Berkeley, CA) and ERK1 sc-94 (Santa Cruz; Bain et al.
1995).
Gene expression profiling using oligonucleotide micro-
array. Total RNA purified with the TriPure isolation reagent
(Boehringer Mannheim) was repurified with RNeasy mini
kit (Qiagen, Valencia, CA) and was used for experiments
with Murine Genome U74A version 2 GeneChip arrays
(Affymetrix, Santa Clara, CA), which contain probes for
detecting 6,000 well-characterized genes and 6,000
expressed sequence tags. All labeling and hybridization
steps were carried out according to Affymetrix protocols.
Data analysis using Affymetrix software. Scanned micro-
array images were analyzed with the Affymetrix microarray
suite 4.0 software. The software identified differentially
expressed transcripts by comparison of the differences in
values of perfect match to mismatch of each probe pair in
the baseline array (differentiated WT ES cells) to its
matching probepair on theexperimentalarray (differentiated
ΔPBX1
−/− cells). The signal log ratios calculated for each
transcript were converted into fold change using Affymetrix
recommended formula. The results of comparison of the
WT and two PBX1 mutant clones were cross-compared,
and 117 transcripts were consistently deregulated in both
mutant clones selected (see Electronic Supplementary
Material).
Results
First allele targeting. The linearized PBX1
flox1 construct
(Fig. 1a) was electroporated into a 129/Ola background
E14 ES cell line and cultured on the embryonic fibroblast
feeder layers, in the presence of LIF, according to standard
protocol (Wasserman et al. 1993). This strategy was chosen
to create both ES cells for differentiation and generate
transgenic knockout mice with the same approach. Follow-
ing positive selection in G418, homologous recombinant
clones were identified by Southern blot analysis using
HindIII digest and the 5′ external Southern blot probe
(Fig. 2a). This probe hybridizes to the 8-kb fragment of the
wild-type allele and the 16-kb fragment of a correctly
targeted allele (Fig. 2a). The homologous recombination
events, detected by Southern blot, were confirmed by PCR
amplification of the 5′ and 3′ ends of the targeting vector,
with one primer based on the sequence inside and one
external to the vector sequence (Fig. 2b).
CRE recombination. Two homologous recombination pos-
itive clones were expanded and electroporated with 20 μg
of CMV-Cre expression vector (kind gift of Dr. Florian
Figure 3. Morphology of the wild-type E14, mutant ΔPBX1
+/−, and
ΔPBX1
−/− ES cells growing undifferentiated on the embryonic
fibroblast and differentiating upon aggregation in the presence of
RA. (a, b) Low-magnification digital images of the colonies of
undifferentiated WT and ΔPBX1
−/− embryonic stem cells. (c, d) The
same colonies photographed at higher magnification. WT and mutant
cells grow in sharp-bordered colonies characteristic of undifferentiated
ES cells. (e, f) Embryoid bodies formed by each of the ES cell clones
as a result of aggregation in non-adhesive dishes followed by RA
induction. (g, h) Morphology of differentiated ES cells 9 d after
reattachment to the adhesive media. The ΔPBX1
−/− cells have a
flattened appearance as they spread in the surroundings of the
reattached aggregates.
PBX1 IS DISPENSABLE FOR NEURAL COMMITMENT OF RA-TREATED ES CELLS 255Otto). In the next step, two recombinant clones with the
excised selection cassette and exon-6 sequences were
selected in a PCR-based screen from each of the ES cell
sub-lines (data not shown).
Second allele targeting. A single clone of Cre-treated cells,
from which both the target sequence containing exon-6 and
flanking intronic regions (700 bp upstream and 280 bp
downstream from exon-6) of PBX1 and the selection
cassette had been removed, was subjected to a second gene
copy targeting procedure (Fig. 1b). The targeted sequence
was removed from the PBX1
flox1 vector through BamHI
digest and re-ligation. This PBX1
flox2 plasmid allowed for
direct inactivation of the second copy of the PBX1 gene
(Fig. 1b). Recombinants were selected in G418 and
screened using the same 5′ external Southern probe as in
the first allele targeting. A shift of the 8 kb WT band to the
properly targeted, 14.5 kb, second allele band was detected
(Fig. 2c). The effect of targeting both alleles was assessed
at the mRNA and protein expression level in the differen-
tiated ΔPBX1
−/− cells (see following subsection).
In vitro ES cells differentiation. The ΔPBX1
−/− cells,
cultured on mitomycin-C-pretreated embryonic fibroblasts
in the standard medium supplemented with LIF, retained
morphological features of undifferentiated ES cells. Fur-
thermore, all analyzed sub-lines expressed the Oct3/4 gene,
indicating their undifferentiated state (Fig. 6). Aggregation
in the media supplemented with 1% fetal calf serum and
RA was employed in order to induce neuro-ectodermal
differentiation, as described in “Materials and Methods”.
WT and ΔPBX1
−/− cells cultured in the non-adhesive
bacterial grade dishes formed embryoid bodies (Fig. 3e–f),
which, stimulated by RA, differentiated into morphologi-
cally distinguishable cell types (Fig. 3g–h). Wild-type cells
grew densely and acquired predominantly bead-like forms
structured into grainy nests (Fig. 3g). On the contrary, most
of the differentiated ΔPBX1
+/− and ΔPBX1
−/− cells had a
flat morphology, resembling mesenchymal cells (Fig. 3h).
Targeted deletion of exon-6 and flanking intronic regions
results in the expression of Δ(280-370)PBX1 mutant
protein. In order to determine the effect of targeting both
alleles on mRNA and protein expression, we performed RT-
PCR, real-time PCR, and Western blot analysis of differ-
entiated cells. As expected, in the RT-PCR where one of the
primers was designed to recognize PBX1 exon-6 region, no
product could be detected in the ΔPBX1
−/− cells (Fig. 1a,
Electronic Supplementary Material).
Reactions with primers designed to amplify the coding
sequence of PBX1 resulted in a single band corresponding to
mutant cDNA (Fig. 1b, Electronic Supplementary Material).
Subsequent cloning and sequencing of the transcript revealed
lack of the sequences encoded by exon-6 and exon-7.
Observed exon-7 skipping and loss of alternative splicing of
exon-8 resulted from deletion of intronic splicing regulatory
sequences (Fig. 2, Electronic Supplementary Material).
Since the lack of the exon-6 and exon-7 sequences does
not result in a frame shift, the mutant cDNA encodes a
protein lacking amino acids 280–370, termed here Δ(280–
370)PBX1 (for the cDNA evidence, see Fig. 2 of Electronic
Supplementary Material). The C-terminal 70 AA remains in
the ΔPPBX1 translated protein. Since the antibody we used
is directed against the C terminus of all three paralogues,
PBX1/2/3, in Western blot, we detected expression of the
Δ(280–370)PBX1 mutant protein in ΔPBX1
+/− and
ΔPBX1
−/− cells (Fig. 4).
Interestingly, Western blot revealed a large amount of
full-length PBX1/2/3 protein (band above the 49-kDa
marker) detected by the PBX1/2/3 antibody. In order to
further explain this observation, we quantified PBX2 and
Figure 4. Analysis of PBX protein and mRNA expression. (a)
Western blot analysis of PBX1/2/3 expression in the differentiated
WT, ΔPBX1
+/−,a n dΔPBX1
−/− cells on the ninth day after
reattachment to adhesive cell culture dishes. Immunodetection of
actin served as the loading control and was carried out on the same
blots following PBX antibody striping. (b) Real-time PCR quantifi-
cation of PBX2 and PBX3 transcripts in differentiated WT cells and
two ΔPBX1
−/− clones on the ninth day after reattachment to adhesive
cell culture dishes.
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u p r e g u l a t e da l m o s tt w o f o l da n dm o r et h a n5 - f o l di n
ΔPBX1
−/− cells compared with WT cells, respectively.
Therefore, a high level of WT PBX protein expression in
the differentiated ΔPBX1
−/− cells correlates with relative
abundance of PBX3 transcripts (Fig. 4). See “Discussion”
for further comments on this observation.
Comparativegenome wide expressionprofilesofdifferentiated
WTandΔPBX1
−/− cell lines. Total RNA from differentiated,
RA-induced, day 9 post-attachment WT and ΔPBX1
−/− cell
populations (one clone of wild-type cell and two clones of
ΔPBX1
−/− cells) was hybridized to the Affymetrix
Mu_U94Av2 microarray. A total of 680 genes for the first
ΔPBX1
−/− clone and 473 genes for the second ΔPBX1
−/−
clone were differentially expressed (two-fold or more differ-
ence) in comparison to the WT cells. Out of those, 117
commonly regulated genes were identified in both analyzed
clones.
A selection of the 117 gene regulations is presented in Fig. 5
and the complete list is accessible at Tables 1, 2,a n d3 of
Electronic Supplementary Material (MS Excel® format
available).
Differentiated ΔPBX1
−/− cells exhibit intensified expression
of neural and muscle specific genes. Nine muscle (Fig. 5b)
and ten neuron (Fig. 5a) specific genes were consistently
upregulated in both clones of ΔPBX1
−/− cells. Among
those, expression of striated smooth and cardiac-muscle-
specific actin isoforms indicated that the ΔPBX1
−/− cells
had acquired a muscle phenotype.
Interestingly, expression of reelin, a gene known to play
an important role both in brain development and neuro-
muscular junction formation, was upregulated in both
Figure 5. The microarray-based comparative gene expression profil-
ing of differentiated ΔPBX1
−/− and WT cells. Represented are
regulations consistently observed in two clones of ΔPBX1
−/− cells.
Upper and lower bars represent values of gene deregulation in
ΔPBX1
−/− clone-1 and ΔPBX1
−/− clone-2, respectively, as compared
to the WT cells. Fold change values are depicted next to the bars.
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−/− clones (Quattrocchi et al. 2003).
Expression of two EGF-related growth factors, amphiregu-
lin (L41352) and NELL2 (U59230), reported to function as
potent mitogens for the neural stem cells in vitro (Falk and
Frisen 2002; Aihara et al. 2003) was also increased. Other
neural genes, upregulated in differentiated ΔPBX1
−/− cells,
play roles in such processes as:
(a) Cell adhesion: catenin alpha-2 (D25281; Uchida et al.
1994), sialyltransferase-8 (X99646; Kojima et al.
1995a, b) and
(b) Cytoskeleton regulation: neuronal intermediate fila-
ment protein (L27220), microtubule-associated protein
tau (M18775; Lee et al. 1988), mouse brain H5
(X61452; Kato 1992).
A slight increase of N-CAM and 3.7-fold increase of
GFAP expression was observed (Table 1,E l e c t r o n i c
Supplementary Material).
Not only the neuron-specific genes but also genes for
skeletal muscle like alpha1-actin, for cardiac muscle like
myosin-heavy polypeptide 7, and for smooth muscles like
h2-calponin were upregulated (Table 3, Electronic Supple-
mentary Material)
Decreased expression of trophectoderm and endothelial
marker genes. In addition, we detected pronounced differ-
ences in trophectodermal marker gene expression between
differentiated WT and ΔPBX1
−/− cells. Expression of
spongiotrophoblast-specific gene Tpbpa (X17071; Lescisin
et al. 1988), trophoblast giant-cell-specific placental lac-
togen-II (M85067), and proliferin (K03235; Adamson et al.
2002) were downregulated (Fig. 5c). Similarly, genes
demarcating epithelial cells derived from endoderm and
mesoderm, e.g., vascular-specific endothelial-specific re-
ceptor tyrosine kinase (X71426) were downregulated
(Fig. 5c; Sato et al. 1993).
Aquaporin1/CHIP28 (L02914), which is expressed pre-
dominantly in endothelium of kidney, lung, trachea, and
heart, but also in placental syncytial trophoblast cells
(Hasegawa et al. 1994), and colipase (AA710635),
expressed in pancreas, stomach, and colon (D’Agostino et
al. 2002), also showed decreased expression. Since colipase
exhibited the strongest downregulation within this group of
genes, we have further confirmed its deregulation in
Northern blot, which revealed that whereas expression of
colipase was strongly induced during WT ES cells
differentiation, it remained silent in ΔPBX1
+/− and
ΔPBX1
−/− cells (Fig. 6). Furthermore, deregulations of
Figure 6. Differentiated ΔPBX1
+/− and ΔPBX1
−/− cells do not
express IGF2, IGF2R, and colipase genes. Total RNA (15 μg/lane)
isolated from undifferentiated (0) and differentiated (9)W T ,ΔPBX1
+/−,
and ΔPBX1
−/− embryonic stem cells was used in the Northern blot
as described in “Materials and Methods”. Genotypes and stages of
differentiation are assigned above the panel: (0) = undifferentiated,
(9) = ninth day post-attachment of embryoid bodies to adhesive
culture dishes. Efficiency of blotting was controlled by staining
RNA on the membrane with ethidium bromide (top of the panel).
b
258 JÜRGENS ET AL.aquaporin1/CHIP28 (L02914) and endothelial-specific re-
ceptor tyrosine kinase (X71426) were confirmed by real-
time PCR (Fig. 3, Electronic Supplementary Material).
Deregulation of imprinted genes: IGF2, IGF2R, H19, DLK-
1, GTL-1, and neuronatin. Interestingly, the microarray
experiments resulted in the discovery of the striking
downregulation of insulin growth factor 2 (X71922) as
well as its receptor (U04710) in ΔPBX1
−/− cells (Fig. 5d).
Consistently, Northern blot analysis revealed that IGF2
was expressed only in differentiated wild-type cells (Fig. 6).
The IGF2 receptor was expressed in all undifferentiated
cells and differentiated WT cells, whereas in differentiated
ΔPBX
+/− and ΔPBX1
−/− cells, its expression was barely
detectable. This IGF2 deregulation prompted us to check
the expression of another imprinted gene, H19, known to
share common regulatory sequences with IGF2 (Srivastava
et al. 2000). Northern blot revealed H19 expression to be
intensified in ΔPBX1
+/− and both ΔPBX1
−/− cells (Fig. 6).
Similarly, H19, IGF1, and IGF1R were also slightly
upregulated in the differentiated knockout cells (Fig. 6).
Interestingly, three other imprinted genes, GTL-2 (Y13832),
DLK-1 (Z12171), and neuronatin (X83569), were also
deregulated (Fig. 5c). GTL-2, like H19, is expressed from
the maternal allele (Schmidt et al. 2000; Takada et al.
2000). Its expression was induced in the differentiated
ΔPBX1
−/− cells. The paternally expressed DLK-1 gene
encodes a homologue of the Notch-Delta family of
developmental regulated signaling molecules (Laborda
2000) and is co-regulated with GTL-2. Its expression was
silenced in the ΔPBX1
−/− clones (Fig. 5c). Expression of
neuronatin (NNAT) was induced in mutant cells. The gene
is normally transcribed from the unmethylated paternal
allele in neural tissue and CD34-positive blood cell
progenitors (Kuerbitz et al. 2002). Deregulation of
imprinted genes was further confirmed by Northern blot
(Fig. 6) or real-time PCR (Fig. 3, Electronic Supplementary
Material).
Expansion of neural cell lineage in differentiating
ΔPBX1
−/− ES cells. The presence of neurons in the
populations of differentiated WT and ΔPBX1
−/− cells
was confirmed by cytoimmunochemical staining with
antibody against a post-mitotic neural marker beta-III-
tubulin (Tuj1; Mann and Chan 1996). We observed
outgrowths of neural processes in the surroundings of
differentiated aggregates of both WT and PBX1 mutant
cells; it was, however, most pronounced in the mutant cell
cultures (Fig. 7a–d). Subsequently, the neural cell popula-
tions were quantified by fluorescence-activated cell sorting
(FACS) of anti-β-III-tubulin-stained cells (Fig. 7e,f). A
marked increase (~5%) in Tuj1-positive cell numbers was
detected in cultures of differentiated ΔPBX1
−/− cells as
compared with WT cells.
Supplemental information online. The relative fold change
values of gene expression are stored in the Excel file format
and can be accessed at http://www.uniklinik-freiburg.de/
medizin1/live/permalink/scheele2009.html.
Discussion
Overview of the experimental model. Utilizing the Cre–
loxP system, we targeted a functionally important part of
the homeodomain of PBX1 in ES cells. Genomic modifi-
Figure 7. RA-treated ΔPBX1
−/− ES cells differentiate into neurons.
(a, b) Confocal microscopy images of differentiated WT and
ΔPBX1
−/− embryonic stem cells on the ninth day post-reattachment
of embryoid bodies to adhesive media. (c, d) Expression of neuron-
specific class III beta-tubulin (red) and extracellular signal-regulated
kinases 1 (ERK1, green) were visualized by indirect immunofluores-
cence. A beta-III-tubilin composite of the same images. (e, f) FACS-
based quantification of the beta-III-tubulin-stained, neural cell
populations derived in WT (e) and ΔPBX1
−/− (f) cell cultures.
PBX1 IS DISPENSABLE FOR NEURAL COMMITMENT OF RA-TREATED ES CELLS 259cation resulted in expression of the Δ(280–370)PBX1
mutant protein (Fig. 4.). Multiple in vitro experiments and
structural data have indicated that the 280–370 a.a. region
facilitates both PBX1–HOX and PBX1–DNA interactions
(Lu and Kamps 1996; Peltenburg and Murre 1997; Jabet
et al. 1999; Piper et al. 1999; LaRonde-LeBlanc and
Wolberger 2003).
By employing DNA microarray technology, we com-
pared transcriptional profiles of in vitro differentiated WT
and ΔPBX1
−/− ES cells. In the following subsections, we
discuss functional aspects of the identified gene regulations.
ΔPBX1
−/− ES cells express neural genes. Cell aggregation
and RA treatment inmedia withlow serum content are known
toleadtoefficient neuroectodermal differentiationofEScells.
In the process of differentiation, various genes are expressed
in a specific temporal order. Some of them are expressed by
undifferentiated ES cells (OCT4, BMP4; Niwa et al. 2000;
Ying et al. 2003) and others are upregulated during early
differentiation (PAX6, Nestin, OTX1; Okabe et al. 1996;
Gajovic et al. 1997), still others during late differentiation
(β-III-tubulin, GFAP, N-CAM; Bain et al. 1995; Fraichard et
al. 1995). Varieties of genes active in this process were
revealed by a recent survey of the ES cells to neural lineage
differentiation transcriptome (Ahn et al. 2004).
In the current study, we compared transcriptomes of WT
and ΔPBX1
−/− mutant cells. Our results indicate that
ΔPBX1
−/− mutant cells not only retain the capability to
express neural genes in response to RA treatment but also
express them at higher levels as compared with WT cells.
Consistently, FACS analysis revealed relative expansion of
β-III-tubulin-expressing cell population, correlating with
widespread outgrowth of neural processes in cultures of
differentiated PBX1 mutant cells (Fig. 7a–d). We conclude
that a greater proportion of ΔPBX1
−/− mutant cells undergo
neural differentiation as compared to WT cells. We hypoth-
esize that the relative abundance of PBX3 transcripts in
populations of differentiated ΔPBX1
−/− cells is a direct result
of neural population expansion. Transcripts of PBX3 were
recently found to be upregulated in the ES cells differentiating
to midbrain and hindbrain neurons (Ahn et al. 2004).
Consistently, PBX3 expression in the mid-gestation mouse
embryo is restricted to the central nervous system; PBX3-
d e f i c i e n tm i c eh a v eb e e ns h o w nt od i ef r o mc e n t r a l
respiratory failure due to abnormal activity of inspiratory
neurons in the medulla (Rhee et al. 2004). Furthermore,
Knoepfler and Kamps (1997) have shown that retinoic acid
upregulates PBX protein abundance coincident with transcrip-
tional activation of Hox genes in P19 embryonal carcinoma
cell undergoing neuronal differentiation. Using an approach
different from double-allele knockout, other investigators
applied SI-RNA technique to eliminate expression of PBX1
and the related PBX2 and PBX3 genes. They could show that
PBX proteins are required for RA-induced differentiation of
P19 cells (Qin et al. 2004). Not only in transformed cell lines
but also in the rat model did the expression of PBX1 in the
subventricular zone precursor cells suggest a role of PBX1 in
mammalian neurogenesis (Redmond et al. 1996).
Deregulation of myogenic, endothelial, and trophectoder-
mal genes. In addition, genetic markers of other cell
lineages were found to be deregulated. Intensified expres-
sion of muscle-specific genes (Fig. 5b) accompanied that of
neural markers. Based on our microarray data, we can
hypothesize that mutant cells differentiate into two pre-
dominant neural and muscle cell lineages. Alternatively,
expression of both neural and muscle-specific genes could
be attributed to expansion of the common neuromuscular
progenitor cell population.
Mouse ES cells, although derived from the epiblast (Brook
and Gardner 1997), which, during gastrulation, does not
contribute to the trophectodermal lineage (Beddington and
Robertson 1989), are capable of acquiring trophectodermal
phenotypes upon withdrawal of LIF (Niwa et al. 2000). Our
results are in agreement with this observation, as the high
levels of trophectodermal marker gene expression were
detected in differentiated WT ES cells. However, differenti-
ated ΔPBX1
−/− cells exhibited decreased expression of
trophectoderm markers as well as endoderm-derived epithe-
lial genes, suggesting involvement of PBX1 in the molecular
program leading to commitment into those lineages (Fig. 5c).
Deregulation of imprinted genes in ΔPBX1
−/− cells. In-
terestingly, the microarray experiment resulted in the
discovery of very strong downregulation of IGF2 and IGF2r
genes in the knockout cells. Whereas in WT cells IGF2 and
IGF2r expression were strongly induced during differenti-
ation, it remained uninduced in differentiating mutant cells.
Loss of expression of these genes in ΔPBX1
+/− and
ΔPBX1
−/− cells could be explained either by their inability
to differentiate into IGF2-a n dIGF2r-expressing cell
populations or by loss of PBX1-mediated transcriptional
regulation. A strong argument against the hypothesis of the
cell population shift as a major reason for the loss of IGF2
expression is delivered by the coordinate upregulation of
the H19 gene. It has been shown that expression of these
two genes in endoderm and mesoderm relies on a common
set of enhancers and is almost identical spatially and
temporarily (Leighton et al. 1995). Interestingly, deregula-
tion of IGF2, IGF2r, and H19 genes in PBX1Δ280–370
mutant expressing cells resembles the situation in the DNA-
methyltransferase-defficient (DNMT-1) knockout embryos
where transcription of IGF2 and its receptor is completely
abolished and the normally inactive paternal copy of H19
gene becomes activated (Li et al. 1993). Additionally, two
other imprinted genes, GTL-2 and neuronatin, were also
260 JÜRGENS ET AL.found to be deregulated in ΔPBX1
−/− cells (Takada et al.
2002; Lin et al. 2003). Expression of all these genes is
crucially dependent on DNA methylation (Li et al. 1993,
2003). It is therefore tempting to speculate that PBX1 has a
function in establishing their methylation patterns.
Conclusions
In conclusion, our experimental model yielded the discovery
of a variety of new genes whose expression is associated
with PBX1 function. Identification of possible links between
their deregulations and the phenotype of previously de-
scribed PBX1 knockout mice awaits future investigation.
The loss of IGF2 expression in differentiated ΔPBX1
−/−
cells is especially interesting in the context of decreased
cellular proliferation rate in developing bone, pancreas, the
hematopioetic system, kidney, and the male genital ridge of
PBX1 knockout mice (DiMartino et al. 2001; Schnabel et
al. 2001, 2003a, b; Selleri et al. 2001; Kim et al. 2002).
Development of most of these organs has been previously
linked to the mitogenic function of IGF2 (Van Wyk and
Smith 1999; Zumkeller and Burdach 1999; Kido et al.
2002; Kim et al. 2002). In particular, the roles of PBX1 and
IGF2 are well recognized in normal pancreas development
(Kido et al. 2002; Kim et al. 2002). Several studies have
demonstrated that exocrine pancreatic development is cru-
cially dependent upon mesenchymal/epithelial interactions,
suggesting that exocrine growth factors play an essential role
in this process (Jonsson et al. 1994; Sanvito et al. 1994;
Gittes et al. 1996; Rose et al. 1999). Additionally, formation
of acinary cell structures in vitro could be rescued in
PBX1
−/− explants by WT mesoderm tissue in recombination
experiments (Kim et al. 2002). However, PBX1-regulated
mesodermal growth factors, capable of rescuing exocrine
pancreatic cell differentiation, were not identified.
Our data open a new possibility whereby PBX1
influences embryonic growth as well as endoderm and
trophectoderm differentiation through regulation of the
imprinted genes IGF2 and IGF2r.
Furthermore, we establish that PBX1 interactions with
HOX and DNA are dispensable for neural gene expression.
The last is interesting in the light of a recent report on the
permissive role of PBX proteins in RA-induced neural
differentiation of P19 carcinoma cell line (Qin et al. 2004).
Still, the possible involvement of the PBX1 N-terminal
domain in neural commitment remains to be tested.
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